Astec Lifesciences Limited (ASTEC)
ISIN: INE563J01010 Industry: Agricultural Inputs Sector: Basic Materials Website
2128.8
-18.05(-0.84%)

Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

Pricing Updates

TODAY'S HIGH

2146.3

TODAY'S LOW

2120

52 WEEK HIGH

2288.8

52 WEEK LOW

1275.05

Major Holders

% of Shares Held by
All Insider

72.10%

% of Shares Held by
Institutions

14.52%

% of Float Held by
Institutions

52.04%

Number of Institutions
Holding Shares

12

Company Overview

MARKET CAP

4173.42 Cr.

ETERPRISE VALUE

4454.47 Cr.

NO. OF SHARES

1.96 Cr.

BOOK VALUE

216.091

DIV. YIELD

1.5%

DEBT

320.98 Cr.

GROSS PROFIT

290.86 Cr.

CASH

74.93 Cr.

REVENUE

829.68 Cr.

REVENUE/SHARE

423.446

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments0000
Change To Liabilities0-70.05 Cr.131.15 Cr.-35.54 Cr.
Total cashflows from Investing Activities0-73.10 Cr.-73.81 Cr.-52.49 Cr.
Net Borrowings088.35 Cr.-78.30 Cr.52.72 Cr.
Total Cash from Financing Activities081.33 Cr.-94.53 Cr.37.09 Cr.
Other Liabilities0-18.17 Cr.19.37 Cr.-3.59 Cr.
Total Assets067.30 Lakhs21.96 Lakhs27.60 Lakhs
Net Income065.04 Cr.47.51 Cr.35.73 Cr.
Change in Cash03.08 Lakhs9.58 Lakhs-11.89 Lakhs
Effect of Exchange Rate0000
Total Cash from Operating Activities0-8.16 Cr.168.44 Cr.15.28 Cr.
Depreciation025.14 Cr.22.66 Cr.18.86 Cr.
Other Cashflows from Investing Activities029.41 Cr.-28.67 Cr.26.01 Lakhs
Dividends Paid0-2.93 Cr.-2.93 Cr.-2.93 Cr.
Change to Inventory015.07 Cr.-28.32 Cr.-14.37 Cr.
Change to Account Receivables0-30.17 Cr.-34.37 Cr.-1.02 Cr.
Other Cashflows from Financing Activities0-4.75 Cr.-13.51 Cr.-12.97 Cr.
Change to Net Income04.45 Cr.9.93 Cr.14.74 Cr.
Capital Expenditures0-102.52 Cr.-45.29 Cr.-52.77 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax089.07 Cr.61.35 Cr.55.90 Cr.
Minority Interest013.92 Lakhs32.85 Lakhs31.25 Lakhs
Net Income119.71 Cr.89.71 Cr.68.48 Cr.66.21 Cr.
Selling General Administrative039.40 Cr.30.93 Cr.26.16 Cr.
Gross Profit289.75 Cr.212.97 Cr.187.09 Cr.155.99 Cr.
Ebit119.71 Cr.89.71 Cr.68.48 Cr.66.21 Cr.
Operating Income119.71 Cr.89.71 Cr.68.48 Cr.66.21 Cr.
Other Operating Expenses058.20 Cr.64.51 Cr.44.29 Cr.
Interest Expense0-4.27 Cr.-11.62 Cr.-11.43 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense024 Cr.13.82 Cr.20.13 Cr.
Total Revenue676.56 Cr.558.66 Cr.528.66 Cr.438.20 Cr.
Total Operating Expenses0468.95 Cr.460.17 Cr.371.99 Cr.
Cost of Revenue0345.68 Cr.341.56 Cr.282.21 Cr.
Total Other Income Expense Net10.46 Cr.-64.27 Lakhs-7.13 Cr.-10.31 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.065.06 Cr.47.52 Cr.35.76 Cr.
Net Income Applicable to Common Shares065.04 Cr.47.51 Cr.35.73 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets05.16 Cr.3.56 Cr.2.41 Cr.
Capital Surplus059.83 Cr.58.91 Cr.58.54 Cr.
Total Liabilities0368.26 Cr.324.82 Cr.258.28 Cr.
Stock Holder Equity0309.17 Cr.246.56 Cr.202.48 Cr.
Minority Interest013.92 Lakhs32.85 Lakhs31.25 Lakhs
Other Liabilities048.94 Cr.16.21 Cr.9.30 Cr.
Total Assets0677.58 Cr.571.71 Cr.461.08 Cr.
Common Stock019.58 Cr.19.56 Cr.19.55 Cr.
Retained Earnings0229.32 Cr.167.39 Cr.123.59 Cr.
Other Liabilities05.99 Cr.6.46 Cr.9.47 Cr.
Good Will0000
Treasury Stock043.13 Lakhs69.04 Lakhs78.69 Lakhs
Other Assets018.76 Cr.22.23 Cr.26.67 Cr.
Cash033.88 Lakhs30.81 Lakhs21.23 Lakhs
Current Liabilities0322.27 Cr.318.36 Cr.248.80 Cr.
Long Term Asset Charges0000
Short Long Term Debt279.37 Cr.16.81 Lakhs00
Other Stockholder Equity043.13 Lakhs69.04 Lakhs78.69 Lakhs
Property Plant Equipment0323.22 Cr.214.16 Cr.183.51 Cr.
Total Cur. Assets0330.43 Cr.331.75 Cr.248.47 Cr.
Long Term Investments053 k53 k53 k
Net Tangible Assets0304.01 Cr.243 Cr.200.07 Cr.
Short Term Investments01.45 Cr.00
Net Receivables278.78 Cr.188.68 Cr.192.03 Cr.122.12 Cr.
Long Term Debt040 Cr.00
Inventory0106.09 Cr.121.17 Cr.92.84 Cr.
Accounts Payable0124.81 Cr.202.38 Cr.63.25 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account